Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial, and explains the role the pediatrician can play in care and recruitment.

Investigating mono vs dual therapy for pediatric pulmonary arterial hypertension ...

Colleen Sloan, PA-C, RDN, explores how diet can help manage childhood constipation. "She's so constipated. I give her a laxative, and she eats fruit. What else can I do?" This familiar concern echoes ...

A CDC report shows only 23% of U.S. teens get enough sleep, with disparities highlighting the need for targeted health interventions. The findings regarding sleep behaviors highlight a trend of ...

Across all years in the report, the CDC rated each physical activity trend with a color of red, indicating that trends are going in the "wrong direction." The Youth Risk Behavior Survey (YRBS) Data ...

Immobilized lipase cartridge (Relizorb; Alcresta Therapeutics) can now be used in children down to 1 year of age, following an expanded clearance by the FDA, according to a recent announcement from ...

Susan Carnell, PhD, highlights the nuanced relationship between social media use and binge eating in adolescents, noting the importance of addressing addictive behaviors and seeking support when ...

Manufacturers who use red no. 3 in food and and ingested drugs will have until January 15, 2027 or January 18, 2028, respectively, to reformulate their products. The FDA has revoked the authorization ...

Results from a recent study revealed that compulsive and addictive elements can contribute to the risk of disordered eating. Study investigator Susan Carnell, PhD, explains these findings. Carnell is ...

According to the report, several key dietary behaviors such as daily fruit or vegetable intake among high school students were trending in the wrong direction. The Centers for Disease Control and ...

Of those with a minimum age or minimum interval vaccine dose, 44.9% ended up receiving extra doses to complete a vaccination series. Vaccine doses provided to children outside of the CDC's Advisory ...

Neffy was first approved in September 2024 to treat type 1 allergic reactions in patients who weigh at least 66 lbs (33 kg). ARS Pharmaceuticals has announced new developments for neffy (epinephrine ...